The Trump administration plans to pump millions of dollars into producing more medications in the U.S. as the coronavirus pandemic heightens longstanding concerns about the fragility of the global drug supply chain.
On Tuesday, the Biomedical Advanced Research and Development Authority awarded a $345 million contract to a group led by Virginia-based drug company Phlow Corp. to make medicines that have fallen into short supply. BARDA is an agency within the Department of Health and Human Services that’s responsible for developing medical countermeasures to emergencies.
About 80% of the active ingredients in medications taken in the U.S. come from overseas, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.